Related Experiment Video
Updated: Mar 21, 2026

Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload
Published on: March 14, 2017
Facility-based constraints to exchange transfusions for neonatal hyperbilirubinemia in resource-limited settings
Cecilia A Mabogunje1, Sarah M Olaifa1, Bolajoko O Olusanya1
1Cecilia A Mabogunje, Neonatal Unit, Massey Street Children's Hospital, Lagos, Nigeria.
Insights
Immediate exchange transfusion (ET) for severe neonatal hyperbilirubinemia is crucial but often delayed in low-resource settings. Addressing these delays is vital to prevent kernicterus and improve infant outcomes.
Area of Science:
- Neonatal Medicine
- Pediatric Hematology
- Public Health in LMICs
Background:
- Severe neonatal hyperbilirubinemia poses a risk of acute and chronic bilirubin encephalopathy.
- Clinical guidelines recommend immediate exchange transfusion (ET) to prevent kernicterus.
- Limited data exists on the interval between ET decision and initiation, particularly in low- and middle-income countries (LMICs).
Purpose of the Study:
- To explore potential delays in initiating exchange transfusion (ET) for severe neonatal hyperbilirubinemia in LMICs.
- To identify factors contributing to delays in ET procedures.
- To emphasize the need for timely intervention to prevent kernicterus.
Main Methods:
- Review of available evidence from LMICs concerning the ET process.
- Analysis of stages and potential delays in ET initiation.
- Examination of resource constraints and challenges in LMICs.
Main Results:
- Delays in ET initiation are influenced by factors including intensive phototherapy, laboratory/logistical support, and clinical expertise.
- Challenges in obtaining informed parental consent (religious objections) and financial burdens impede timely ET.
- Secondary delays can occur due to post-treatment bilirubin rebound.
Conclusions:
- Timely exchange transfusion (ET) is critical for managing severe neonatal hyperbilirubinemia and preventing kernicterus.
- Resource limitations and socio-cultural factors in LMICs significantly contribute to ET delays.
- Addressing these delays is essential to enhance the effectiveness of ET and reduce avoidable cases of kernicterus.
Abstract:
Several clinical guidelines for the management of infants with severe neonatal hyperbilirubinemia recommend immediate exchange transfusion (ET) when the risk or presence of acute bilirubin encephalopathy is established in order to prevent chronic bilirubin encephalopathy or kernicterus. However, the literature is sparse concerning the interval between the time the decision for ET is made and the actual initiation of ET, especially in low- and middle-income countries (LMICs) with significant resource constraints but high rates of ET. This paper explores the various stages and potential delays during this interval in complying with the requirement for immediate ET for the affected infants, based on the available evidence from LMICs. The vital role of intensive phototherapy, efficient laboratory and logistical support, and clinical expertise for ET are highlighted. The challenges in securing informed parental consent, especially on religious grounds, and meeting the financial burden of this emergency procedure to facilitate timely ET are examined. Secondary delays arising from post-treatment bilirubin rebound with intensive phototherapy or ET are also discussed. These potential delays can compromise the effectiveness of ET and should provide additional impetus to curtail avoidable ET in LMICs.
Related Concept Videos
Pharmacokinetics in Pediatric Patients: Drug Excretion
Pharmacokinetics in Pediatric Patients: Drug Distribution
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Blood Transfusion and Agglutination
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
Blood Transfusion
Blood Transfusion Overview
A blood transfusion is a medical procedure used to replace blood lost due to injury, surgery, or to treat conditions such as anemia or cancer. During a transfusion, donor blood is...
Rh Blood Group

